Nrx Pharmaceuticals Inc (NRXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 77 | 140 | 267 | N/A | N/A |
| TOTAL | $124 | $216 | $335 | $N/A | $N/A |
| Non-Current Assets | |||||
| Investments And Advances | 69,761 | 69,483 | 69,218 | 0 | 0 |
| TOTAL | $69,761 | $69,483 | $69,218 | $N/A | $N/A |
| Total Assets | $69,885 | $69,699 | $69,553 | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 328 | 204 | 61 | 0 | 0 |
| TOTAL | $376 | $217 | $65 | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 64,510 | 64,482 | 64,488 | 0 | 0 |
| TOTAL | $64,510 | $64,482 | $64,488 | $N/A | $N/A |
| Total Liabilities | $64,885 | $64,699 | $64,553 | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 904 | 904 | 904 | 904 | N/A |
| Common Shares | 3 | 3 | 3 | N/A | N/A |
| Retained earnings | -68 | -96 | -90 | N/A | N/A |
| TOTAL | $5,000 | $5,000 | $5,000 | $N/A | $N/A |
| Total Liabilities And Equity | $69,885 | $69,699 | $69,553 | $0 | $0 |